Close X
Friday, November 15, 2024
ADVT 
International

US Mission in India processes over 1 mn non-immigrant visas in 2023

Darpan News Desk IANS, 28 Sep, 2023 10:48 AM
  • US Mission in India processes over 1 mn non-immigrant visas in 2023

New Delhi, Sep 28 (IANS): The US Mission to India said on Thursday that it has reached and surpassed its goal to process one million non-immigrant visa applications in 2023.

Stating that Indians made over one in 10 visa applications worldwide, the Mission said it has already surpassed the total number of cases processed in 2022 and is processing almost 20 per cent more applications than in pre-pandemic 2019.

“Our partnership with India is one of the United States’ most important bilateral relationships, and in fact one of the most important relationships in the world," US Ambassador to India Eric Garcetti said.

"The ties between our people are stronger than ever, and we will continue our record-setting volume of visa work in the coming months to give as many Indian applicants as possible the opportunity to travel to the United States and experience the US-India friendship firsthand,” Garcetti added.

The Ambassador on Thursday handed over the passport to the one millionth visa holder and said: “… this year we are so proud… we have processed over 1 million visa applications."

Last year ,over 1.2 million Indians visited the US, making this one of the most robust travel relationships in the world.

Indians now represent over 10 per cent of all visa applicants worldwide, including 20 per cent of all student visa applicants and 65 per cent of all H&L-category (employment) visa applicants.

Recognising the continued high demand for its visas, the Mission said that the US continues to invest heavily in our operations in India.

In the past year, the Mission said it expanded its staffing to facilitate more visa processing, and made significant capital improvements to existing facilities, such as the US Consulate in Chennai, and inaugurating a new Consulate building in Hyderabad.

The Mission said that beginning next year, it plans to implement a pilot program that would allow domestic visa renewal for qualified H&L-category employment visa applicants.

MORE International ARTICLES

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US

Some of Trump's trade legacy to linger under Biden

Some of Trump's trade legacy to linger under Biden
Future administrations, be they Democrat or Republican, are unlikely to forget the lessons of 2016 any time soon, a panel of trade experts agreed Thursday.

Some of Trump's trade legacy to linger under Biden